Emily Bay, MD
Psychiatry · Charleston, SCNPI 1588159438
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,858 of the $2,328 with a category attached, or 79.8%. 8 manufacturers reported payments, led by Livanova USA, Inc. at 42.5% of the total. Reporting peaked in 2024 at $1,372 and has fallen 56.1% since, to $602 in 2025.
Across 21 payments — averaging $110.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$989
- Abbott$495
- Otsuka America Pharmaceutical, Inc.$230
- Janssen Scientific Affairs, LLC$128
- Teva Pharmaceuticals USA, Inc.$125
- Davol Inc.$123
- plus $239 from 2 others
What the payments were for
- Travel & lodging$47120%
- Food & beverage$1,85880%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 9 | $989 |
| Abbott | 3 | $495 |
| Otsuka America Pharmaceutical, Inc. | 3 | $230 |
| Janssen Scientific Affairs, LLC | 2 | $128 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Davol Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Neurocrine Biosciences, Inc. | 1 | $117 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy Symmetry Model 8103 Generator$856
- INFINITY$462
- AUSTEDO$125
- Phasix Mesh$123
- Auvelity$122
- REXULTI$118
- INGREZZA$117
How this compares
$2,328 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Charleston
- Ricardo FermoCharleston$262K
- Jacobo MintzerCharleston$132K
- Floyd SalleeCharleston$121K
- Kathleen BradyCharleston$83K
- Jordan SpencerCharleston$62K
- James BallengerCharleston$35K
- Mark HamnerCharleston$24K
- Constance AlexanderCharleston$20K
- Mark GeorgeCharleston$17K
- Lalithkumar SolaiCharleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.